medline.ch Dermatologie Tumoren Anderes

	Overall survival with immune checkpoint inhibitors across treatment settings and clinical and PD-L1-defined subgroups in advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of randomized trials. Front Immunol Wang B, Han X, Shen Z. PMID: 42756417 [PubMed - indexed for MEDLINE]
	Comparative outcomes of neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in locally advanced thoracic esophageal squamous cell carcinoma: a target trial emulation. Front Immunol Li Z, Zhou Q, Xie Q, Wang C, Peng L, Han Y, Leng X, Miao Y, Zhang Q, He W. PMID: 42756384 [PubMed - indexed for MEDLINE]
	Identification of a necroptosis-related lncRNA prognostic signature and the hub RBP HNRNPK in esophageal squamous cell carcinoma. J Int Med Res Zheng S, Yang H, Liu W, Zhi F, Luo H, Feng Y, Lei Y. PMID: 42754824 [PubMed - indexed for MEDLINE]
	Esophageal Cancer. N Engl J Med Xie SH, Smyth E, Lagergren J. PMID: 42748430 [PubMed - indexed for MEDLINE]
	Correlation between interleukin-17 levels and oral manifestations in patients with oral squamous cell carcinoma. Wiad Lek Hadi EA, Al-Daher RI, Hameed AH, Al-Fahham AA. PMID: 42748299 [PubMed - indexed for MEDLINE]
	Exploring spatial heterogeneity of PD-L1 and c-MET expression in oral squamous cell carcinoma. Oral Maxillofac Surg Busse C, Hörner M, Saravi B, Haug L, Gubik S, Kübler A, Müller-Richter U, Rosenwald A, Hartmann S. PMID: 42747499 [PubMed - indexed for MEDLINE]
	Anal Intraepithelial Neoplasia Detection on Routine Colonoscopy: Review of 3550 Patients. JSLS Aleissa M, Busbait SA, Herman K, Singh JP, Bhullar G, Flanagan Synowicz M, Drelichman ER, Mittal VK, Bhullar JS. PMID: 42746562 [PubMed - indexed for MEDLINE]
	Uncovering the Potential of 3D Spheroids for Modeling the Cellular Crosstalk Within the Tumor Microenvironment in HNSCC. Biotechnol J Yadav A, Das U, Singh R, Tyagi S, Ghodeswar A, Mishra S, Kushwaha HR, Singh RP, Chaturvedi R. PMID: 42745651 [PubMed - indexed for MEDLINE]
	Long-term outcome of ablation for anal HSIL: Achieving HSIL-free status is key-A UK-based retrospective cohort study. Colorectal Dis Cuming T, Rozemeijer K, Farrow E, Cappello C, Wait B, Junejo M, Bowring J, Rosenthal AN, Richel O, Nathan M, de Vries HJC, Prins JM. PMID: 42745364 [PubMed - indexed for MEDLINE]
	A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial. Nat Commun Ottensmeier C, Delord JP, Lalanne A, Jamet C, Le Gac AL, Bidet Huang K, Grellier B, Deforges J, Brandely M, Quéméneur E, Bastien B, Tavernaro A, Lacoste G, Schoettel V, Spring-Giusti C, Silvestre N, Marchand JB, Robin S, Dochy E, Ceppi M, Riva A, Yamagata N, Brattas P, Onoguchi K, Yamashita Y, Fontenelle H, Eggert Martinez M, Baker O, Jones T, Schache A, Piaggio E, Bendjama K, Lantz O, Le Tourneau C. PMID: 42744798 [PubMed - indexed for MEDLINE]
	Stratifying the risk of anal high-grade squamous intraepithelial lesion among immunosuppressed women with genital HPV. Front Immunol Matas I, Pifarré M, Torné A, Saco A, Darecka K, Guerra E, Martí C, Bruch J, Cardiel A, Rakislova N, Marimon L, Mayordomo-Bofill I, Victoria I, Alós S, Fusté P, Ordi J, Del Pino M. PMID: 42741372 [PubMed - indexed for MEDLINE]
	Case Report: Small bowel metastasis from esophageal squamous cell carcinoma: a case series and systematic review of clinical characteristics, tropism, and survival outcomes. Front Immunol Zhou M, Liu Y, Huang H, Chen X, Huang Q, Huang S, Yan Z, Chen Y, Lin J, Huang J, Xie G, Hou Y, Huang Y. PMID: 42741216 [PubMed - indexed for MEDLINE]
	Treatment-related lymphopenia predicts long-term survival in locally advanced head and neck cancer: Post-Hoc analysis of a randomized phase III trial. Front Immunol Shayan G, Guo X, Huang X, Wang K, Qu Y, Zhang Y, Wu R, Chen X, Luo J, Zhang J, Wang J, Yi J. PMID: 42741172 [PubMed - indexed for MEDLINE]
	Dynamic survival prediction using longitudinal AGR in unresectable locally advanced esophageal squamous cell carcinoma. Front Immunol Du F, Deng W, Xiao Y, Yu R, Jia J. PMID: 42740913 [PubMed - indexed for MEDLINE]
	Prognostic Relevance and Immune Correlates of DAPK1 Expression and CD4(+)/CD8(+) T-Cell Infiltration in Oral Squamous Cell Carcinoma. Cells Lai HC, Chang KM, Lee CC. PMID: 42738860 [PubMed - indexed for MEDLINE]
	A Proposed Microneedle-Small Extracellular Vesicle System for Localized Adjunctive Treatment of Established Oral Squamous Cell Carcinoma: A Narrative Review and Preclinical Development Perspective. Cells He H, Chen Z, Liu H, Zhang X, Li Z, Yang H, Chen X, Yang Y, Wang Z. PMID: 42738821 [PubMed - indexed for MEDLINE]
	Combination of 5-Aminolevulinic Acid and Indocyanine Green in Photodynamic Therapy for Squamous Cell Carcinoma: An In Vivo Study. Int J Mol Sci Mahmood A, Seo J, Requena MB, Bagnato VS. PMID: 42737592 [PubMed - indexed for MEDLINE]
	Preoperative Inflammatory Blood Indices as Prognostic Markers in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Int J Mol Sci Louizakis A, Tatsis D, Antoniou A, Astreidis I, Stergiadou E, Domvri K, Paraskevopoulos K, Metallidis S, Vahtsevanos K, Cheva A. PMID: 42737539 [PubMed - indexed for MEDLINE]
	Neoadjuvant chemoimmunotherapy with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-2): an open-label, single-arm, phase 2 study. J Immunother Cancer Wei Z, Chen H, Wang D, Li L, Pei Y, Yang H, Wang F, Jin J, Luo Y, Chen F, Liu J, Peng X. PMID: 42731876 [PubMed - indexed for MEDLINE]
	Oncolytic viruses in head and neck cancer: therapeutic promise and translational challenges. Front Immunol Wang H, Shen H, Zhang M, Mou Y, Ren C, Sun Y, Liu W, Sun C, Li D, Li Y, Qu P, Song X. PMID: 42729552 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 61173

Seite 1 von 3059

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung